BioMarin Pharmaceutical Inc (BMRN) Revenue 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.2BFY2025 · since FY2016: $1.1B → $3.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2B | +12.9% |
| FY2024 | $2.9B | +18.0% |
| FY2023 | $2.4B | +15.4% |
| FY2022 | $2.1B | +13.5% |
| FY2021 | $1.8B | -0.8% |
| FY2020 | $1.9B | +9.2% |
| FY2019 | $1.7B | +14.3% |
| FY2018 | $1.5B | +13.5% |
| FY2017 | $1.3B | +17.6% |
| FY2016 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRN financial trends
BMRN Net incomeBMRN Net marginBMRN Gross profitBMRN Gross marginBMRN Operating incomeBMRN Operating marginBMRN Operating cash flowBMRN Free cash flowBMRN Capital expendituresBMRN Return on equityBMRN Stock buybacksBMRN Dividends paidBMRN Total assetsBMRN Total liabilitiesBMRN Shareholders’ equityBMRN overview →